Bendamustine in the treatment of non-Hodgkin’s lymphomas

por Hagemeister, Fredrick, Manoukian, George
Publicado 2009

Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

por Khan, Maliha, Samaniego, Felipe, Hagemeister, Fredrick B., Iyer, Swaminathan P.
Publicado 2021

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up

por Zhou, Hui, Xu-Monette, Zijun Y., Xiao, Ling, Strati, Paolo, Hagemeister, Fredrick B., He, Yizi, Chen, Huan, Li, Yajun, Manyam, Ganiraju C., Li, Yong, Montes-Moreno, Santiago, Piris, Miguel A., Young, Ken H.
Publicado 2020

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

por Wang, Yingjun, Gali, Vasantha Lakshmi, Xu-Monette, Zijun Y., Sano, Dahlia, Thomas, Sheeba K., Weber, Donna M., Zhu, Feng, Fang, Xiaosheng, Deng, Manman, Zhang, Mingzhi, Hagemeister, Fredrick B., Li, Yong, Orlowski, Robert Z., Lee, Hans Chulhee, Young, Ken H.
Publicado 2021

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

por Strati, Paolo, Ahmed, Mohamed Amin, Fowler, Nathan H., Nastoupil, Loretta J., Samaniego, Felipe, Fayad, Luis E., Hagemeister, Fredrick B., Romaguera, Jorge E., Rodriguez, Alma, Wang, Michael, Westin, Jason R., Cheah, Chan, Noorani, Mansoor, Feng, Lei, Davis, Richard E., Neelapu, Sattva S.
Publicado 2020

PD-L1(+) macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

por Steiner, Raphael E., Parra, Edwin R., Vega, Francisco, Feng, Lei, Westin, Jason R., Neelapu, Sattva S., Strati, Paolo, Green, Michael R., Flowers, Christopher R., Solis, Luisa M., Wistuba, Ignacio I., Ahmed, Sairah, Nair, Ranjit, Hagemeister, Fredrick B., Noorani, Mansoor, Marques-Piubelli, Mario L.
Publicado 2023

Lenalidomide plus rituximab (R(2)) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial

por Becnel, Melody R., Nastoupil, Loretta J., Samaniego, Felipe, Davis, Richard E., You, M. J., Green, Michael, Hagemeister, Fredrick B., Fanale, Michelle A., Fayad, Luis E., Westin, Jason R., Wang, Michael, Oki, Yasuhiro, Forbes, Sheryl G., Feng, Lei, Neelapu, Sattva S., Fowler, Nathan H.
Publicado 2019

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

por Sheu, Tommy, Milgrom, Sarah A., Andraos, Therese Y., Gunther, Jillian R., Chi, Linda, Nastoupil, Loretta, Fowler, Nathan, Oki, Yasuhiro, Fanale, Michelle A., Fayad, Luis E., Hagemeister, Fredrick, Neelapu, Sattva S., Medeiros, L. Jeffrey, Hosing, Chitra, Nieto, Yago, Ahmed, Sairah, Alousi, Amin M., Dabaja, Bouthaina, Pinnix, Chelsea C.
Publicado 2018

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

por Strati, Paolo, Varma, Ankur, Adkins, Sherry, Nastoupil, Loretta J., Westin, Jason R., Hagemeister, Fredrick B, Fowler, Nathan H, Lee, Hun J., Fayad, Luis E., Samaniego, Felipe, Ahmed, Sairah, Chen, Yiming, Horowitz, Sandra, Arafat, Sara, Johncy, Swapna, Kebriaei, Partow, Mulanovich, Victor Eduardo, Heredia, Ella Ariza, Neelapu, Sattva S.
Publicado 2020

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

por Chihara, Dai, Fanale, Michelle A., Miranda, Roberto N., Noorani, Mansoor, Westin, Jason R., Nastoupil, Loretta J., Hagemeister, Fredrick B., Fayad, Luis E., Romaguera, Jorge E., Samaniego, Felipe, Turturro, Francesco, Lee, Hun J., Neelapu, Sattva S., Rodriguez, M. Alma, Wang, Michael, Fowler, Nathan H., Davis, Richard E., Medeiros, L. Jeffrey, Oki, Yasuhiro
Publicado 2018

SIRPα(+) macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab

por Marques-Piubelli, Mario L., Parra, Edwin R., Feng, Lei, Soto, Luisa Solis, Gallardo, Mariana, Gouni, Sushanth, Samaniego, Felipe, Noorani, Mansoor, Hagemeister, Fredrick B., Westin, Jason R., Lee, Hun Ju, Rodriguez, Maria A., Neelapu, Sattva S., Gunther, Jillian R., Fowler, Nathan H., Flowers, Christopher R., Wistuba, Ignacio I., Nastoupil, Loretta J., Vega, Francisco, Strati, Paolo
Publicado 2022

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

por Cherng, Hua-Jay J., Alig, Stefan K., Oki, Yasuhiro, Nastoupil, Loretta J., Fayad, Luis, Neelapu, Sattva S., Turturro, Francesco, Hagemeister, Fredrick, Craig, Alexander F. M., Macaulay, Charles W., Rodriguez, Maria Alma, Lee, Hun Ju, McDonnell, Timothy J., Flowers, Christopher R., Vega, Francisco, Green, Michael R., Feng, Lei, Kurtz, David M., Alizadeh, Ash A., Davis, R. Eric, Westin, Jason R.
Publicado 2022

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

por Cherng, Hua-Jay J., Sun, Ryan, Sugg, Bryant, Irwin, Russell, Yang, Haopeng, Le, Cao Cuong, Deng, Qing, Fayad, Luis, Fowler, Nathan H., Parmar, Simrit, Steiner, Raphael, Hagemeister, Fredrick, Nair, Ranjit, Lee, Hun Ju, Rodriguez, Maria, Samaniego, Felipe, Iyer, Swaminathan P., Flowers, Christopher R., Wang, Linghua, Nastoupil, Loretta J., Neelapu, Sattva S., Ahmed, Sairah, Strati, Paolo, Green, Michael R., Westin, Jason
Publicado 2022

EBV-positive DLBCL frequently harbors somatic mutations associated with clonal hematopoiesis of indeterminate potential

por Li, Yong, Xu-Monette, Zijun Y., Abramson, Jeremy, Sohani, Aliyah R., Bhagat, Govind, Tzankov, Alexandar, Visco, Carlo, Zhang, Shanxiang, Dybkaer, Karen, Pan, Zenggang, Xu, Min, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Go, Heounjeong, van Krieken, J. Han, Winter, Jane N., Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Piris, Miguel A., Wang, Yingjun, Zhang, Mingzhi, Young, Ken H.
Publicado 2022

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

por Albitar, Maher, Zhang, Hong, Goy, Andre, Xu-Monette, Zijun Y., Bhagat, Govind, Visco, Carlo, Tzankov, Alexandar, Fang, Xiaosheng, Zhu, Feng, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Parsons, Benjamin M., van Krieken, J. Han, Piris, Miguel A., Winter, Jane N., Li, Yong, Xu, Bing, Young, Ken H.
Publicado 2022

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

por Deng, Manman, Zhang, Mingzhi, Xu-Monette, Zijun Y., Pham, Lan V., Tzankov, Alexandar, Visco, Carlo, Fang, Xiaosheng, Bhagat, Govind, Zhu, Feng, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Hsi, Eric D., Choi, William W. L., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Parsons, Benjamin M., van Krieken, J. Han, Piris, Miguel A., Winter, Jane N., Hagemeister, Fredrick, Alinari, Lapo, Li, Yong, Andreeff, Michael, Xu, Bing, Young, Ken H.
Publicado 2020

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

por You, Hua, Xu-Monette, Zijun Y., Wei, Li, Nunns, Harry, Nagy, Máté L., Bhagat, Govind, Fang, Xiaosheng, Zhu, Feng, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Chiu, April, Tam, Wayne, Zu, Youli, Hsi, Eric D., Hagemeister, Fredrick B., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Benjamin M., Van Krieken, J. Han, Piris, Miguel A., Winter, Jane N., Li, Yong, Au, Qingyan, Xu, Bing, Albitar, Maher, Young, Ken H.
Publicado 2021

Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

por Han, Guangchun, Deng, Qing, Marques-Piubelli, Mario L., Dai, Enyu, Dang, Minghao, Ma, Man Chun John, Li, Xubin, Yang, Haopeng, Henderson, Jared, Kudryashova, Olga, Meerson, Mark, Isaev, Sergey, Kotlov, Nikita, Nomie, Krystle J., Bagaev, Alexander, Parra, Edwin R., Solis Soto, Luisa M., Parmar, Simrit, Hagemeister, Fredrick B., Ahmed, Sairah, Iyer, Swaminathan P., Samaniego, Felipe, Steiner, Raphael, Fayad, Luis, Lee, Hun, Fowler, Nathan H., Flowers, Christopher R., Strati, Paolo, Westin, Jason R., Neelapu, Sattva S., Nastoupil, Loretta J., Vega, Francisco, Wang, Linghua, Green, Michael R.
Publicado 2022